Skip to main content
. Author manuscript; available in PMC: 2017 Jan 11.
Published in final edited form as: J Nucl Med. 2015 Feb 19;56(4):616–621. doi: 10.2967/jnumed.114.149484

FIGURE 5.

FIGURE 5

(A) Representative coronal PET images of mice at 1, 2, 6, and 24 h after injection of 64Cu-NOTA-tenascin-C aptamer. White arrow indicates tumor. (B) T/M and T/B ratios of 64Cu-NOTA-tenascin-C aptamer over time. Results are presented as average of 5 mice ± SD. *Significance between 6 and 24 h and 1 and 2 h. (C) Comparison of tumor uptake between 64Cu-NOTA-tenascin-C aptamer and 64Cu-NOTA-Sc aptamer (n = 5/group). *Significance between aptamer and Sc aptamer tumor uptake.